Glioblastoma and Reducing Inflammation
Feb 11
Two new courses this month:
Course ONE > Beyond the Standard Protocol: Complementary Support for Glioblastoma
Course ONE > Beyond the Standard Protocol: Complementary Support for Glioblastoma
Glioblastoma Multiforme (GBM) remains one of the most formidable challenges in modern oncology. As the most aggressive form of brain tumour, survival rates have remained stubbornly stagnant for nearly three decades despite advancements in neurosurgery and imaging.
For practitioners and patients alike, the search for supportive therapies that can work alongside conventional radiation and chemotherapy is more critical than ever. Recent research into complementary medicine is beginning to offer a more nuanced, integrative approach to managing this difficult diagnosis.
The Role of Integrative Care
Complementary medicine in the context of GBM isn't about replacing standard care; it’s about biological optimisation. By understanding the tumour microenvironment, practitioners can identify natural compounds that may inhibit tumour growth pathways or alleviate the severe side effects of conventional treatment.
Promising Areas of Research
Several evidence-based interventions are gaining traction in clinical and in-vitro studies:
Medicinal Cannabis: Beyond symptom management, researchers are investigating how cannabinoids affect the tumour microenvironment and their potential synergistic effects with chemotherapy.
Botanical Powerhouses: Compounds like Turmeric (Curcumin) and Boswellia are being studied for their multi-faceted anti-cancer pathways. Boswellia, in particular, shows promise in managing radiation-induced cerebral edema (brain swelling), potentially reducing the need for high-dose steroids.
Metabolic Support: Coenzyme Q10 is being explored for its role in oxidative balance, while marine-derived extracts like sea cucumber are revealing unique mechanisms of action against aggressive cell lines.
Hyperbaric Oxygen Therapy (HBOT): This involves breathing pure oxygen in a pressurised environment, which may enhance the effectiveness of radiation treatment by reducing tumor hypoxia.
A New Era of Classification
The 2021 WHO reclassification of central nervous system tumours has shifted the focus toward genetic profiling. Understanding the specific molecular markers of a tumour allows for a more personalised integrative strategy, ensuring that complementary therapies are tailored to the patient’s specific biological landscape.
While the road ahead for GBM treatment is long, the integration of rigorous science with complementary strategies offers a beacon of hope for improving quality of life and patient outcomes.
---------------
Course TWO > Cracking the Code: Using Genetic Testing to Silence Chronic Inflammation
Course TWO > Cracking the Code: Using Genetic Testing to Silence Chronic Inflammation
We often think of inflammation as a temporary response to an injury, a swollen ankle or a red scratch. However, chronic, low-grade inflammation is a silent driver behind many of today's most prevalent health issues, from metabolic syndrome to autoimmune disorders.
But why do two people with the same lifestyle have completely different inflammatory responses? The answer lies in our DNA.
The Genetic Threshold
Our genes determine our "inflammatory tone." Genetic variations influence how easily our immune system is triggered and, perhaps more importantly, how efficiently it "shuts off" once a threat is gone. By utilising genetic testing, we can move away from a generic "anti-inflammatory" diet and toward high-precision, personalised care.
Key Insights from Genetic Analysis
Genetic testing allows us to identify specific vulnerabilities in the immune system:
The Vitamin D Connection: It’s not always about how much Vitamin D you take. Specific genes control how your body utilises Vitamin D to regulate inflammation. If your receptors aren't functioning optimally, a standard dose may not be enough.
Histamine Intolerance: Some individuals are genetically predisposed to higher histamine levels, which can manifest as "inflammatory water weight" rather than true fat mass.
Nutrigenomic Dosing: There is a major difference between a "nutritional dose" (to prevent deficiency) and a "nutrigenomic dose" (to override a genetic predisposition). Knowing your 15 most important "inflammation genes" allows for precise supplement and dietary targeting.
Identifying the Triggers
Are you hyper-sensitive to inflammatory triggers? Tools like the "Muffin Test" and specific clinical intake questions can help determine if your body is struggling to restore homeostasis. When we identify these genetic immune variations, we can prioritise the environmental modifications and nutraceuticals that will actually move the needle for your specific biology.
Moving Beyond "Anti-Inflammatory"
Personalised medicine means no longer guessing. By understanding your genetic risk, you can stop fighting a broad war against inflammation and start implementing a surgical strike against the specific pathways that are holding your health back.
It’s time to stop treating inflammation as a mystery and start treating it as a manageable part of your unique genetic blueprint.
All Courses | CE Hours | Help | Students | Presenters | Legals | Reimbursement | Become a Member | About | Contact
Sign-Up to Our Newsletter | Course Updates and News | Freebies and More
More coming your way soon! No spam. Promise.